section name header

Information

[Section Outline]

Nausea refers to the imminent desire to vomit and often precedes or accompanies vomiting. Vomiting refers to the forceful expulsion of gastric contents through the mouth. Retching refers to labored rhythmic respiratory activity that precedes emesis. Regurgitation refers to the gentle expulsion of gastric contents in the absence of nausea and abdominal diaphragmatic muscular contraction. Rumination refers to the regurgitation, rechewing, and reswallowing of food from the stomach.

Pathophysiology !!navigator!!

Gastric contents are propelled into the esophagus when there is relaxation of the gastric fundus and gastroesophageal sphincter followed by a rapid increase in intraabdominal pressure produced by contraction of the abdominal and diaphragmatic musculature. Increased intrathoracic pressure results in further movement of the material to the mouth. Reflex elevation of the soft palate and closure of the glottis protect the nasopharynx and trachea and complete the act of vomiting. Vomiting is controlled by two brainstem areas, the vomiting center and chemoreceptor trigger zone. Activation of the chemoreceptor trigger zone results in impulses to the vomiting center, which controls the physical act of vomiting.

Etiology !!navigator!!

Nausea and vomiting are manifestations of a large number of disorders (Table 40-1 Causes of Nausea and Vomiting).

Evaluation !!navigator!!

The history, including a careful drug history, and the timing and character of the vomitus can be helpful. For example, vomiting that occurs predominantly in the morning is often seen in pregnancy, uremia, and alcoholic gastritis; feculent emesis implies distal intestinal obstruction or gastrocolic fistula; projectile vomiting suggests increased intracranial pressure; vomiting during or shortly after a meal may be due to psychogenic causes or peptic ulcer disease. Associated symptoms may also be helpful: vertigo and tinnitus in Ménière's disease, relief of abdominal pain with vomiting in peptic ulcer, and early satiety in gastroparesis. Plain radiographs can suggest diagnoses such as intestinal obstruction. The upper GI series assesses motility of the proximal GI tract as well as the mucosa. Other studies may be indicated, such as gastric emptying scans (diabetic gastroparesis) and CT scan of the brain.

Complications !!navigator!!

Rupture of the esophagus (Boerhaave's syndrome), hematemesis from a mucosal tear (Mallory-Weiss syndrome), dehydration, malnutrition, dental caries and erosions, metabolic alkalosis, hypokalemia, and aspiration pneumonitis.

TREATMENT

Nausea and Vomiting

Treatment is aimed at correcting the specific cause. The effectiveness of antiemetic medications depends on etiology of symptoms, pt responsiveness, and side effects. Antihistamines such as meclizine and dimenhydrinate are effective for nausea due to inner ear dysfunction. Anticholinergics such as scopolamine are effective for nausea associated with motion sickness. Haloperidol and phenothiazine derivatives such as prochlorperazine are often effective in controlling mild nausea and vomiting, but sedation, hypotension, and parkinsonian symptoms are common side effects. Selective dopamine antagonists such as metoclopramide may be superior to the phenothiazines in treating severe nausea and vomiting and are particularly useful in treatment of gastroparesis. IV metoclopramide may be effective as prophylaxis against nausea when given before chemotherapy. Ondansetron and granisetron, serotonin receptor blockers, and glucocorticoids are used for treating nausea and vomiting associated with cancer chemotherapy. Aprepitant, a neurokinin receptor blocker, is effective at controlling nausea from highly emetic drugs like cisplatin. The atypical antipsychotic agent, olanzapine, can help control and prevent emesis caused by highly emetogenic chemotherapy. Erythromycin is effective in some pts with gastroparesis.

Outline

Section 3. Common Patient Presentations